Correction of dyslipidemia with combined use of beta-sitosterol and polyprenyl phosphates in dogs with type 1 diabetes mellitus-Reference-Cited by-同舟云学术

Correction of dyslipidemia with combined use of beta-sitosterol and polyprenyl phosphates in dogs with type 1 diabetes mellitus

Published:2019-10-01 Issue:5 Volume:2019 Page:12-15
ISSN:2500-4379
Container-title:Russian veterinary journal
language:en
Short-container-title:

Author:

Анников Вячеслав¹,Annikov Vyacheslav²,Наровлянский Александр³,Narovlyanskiy Aleksandr⁴,Санин Александр³,Sanin Aleksandr⁴,Пронин Александр³,Pronin Aleksandr⁴,Кожевникова Татьяна³,Kozhevnikova Tat'yana⁵

Affiliation:

1. ФГБОУ ВПО «Саратовский ГАУ» им. Н.И. Вавилова

2. Saratov State Agrarian University named after N.I. Vavilov

3. Федеральное государственное бюджетное учреждение «Национальный исследовательский центр эпидемиологии и микробиологии имени Н.Ф. Гамалеи» Минздрава России

4. The Gamaleya Scientific Research Institute of Epidemiology and Microbiology

5. Gamaleya Scientific Research Institute of Epidemiology and Microbiolo

Abstract

This study considers the efficiency of use of a combined drug based on beta-sitosterol and polyprenyl phosphates in dogs with type I diabetes mellitus complicated by hyperlipidemia. It was shown that after 1 month of the therapy, there was a significant decrease of the level of cholesterol, triglycerides and glucose vs. control animals. After 2 months of the therapy, in the control group the level of cholesterol and triglycerides was at the upper limit of the norm, which can lead to an exacerbation of the disease in future.

Publisher

Publishing House Logos Press

Reference12 articles.

1. Annikov V.V., Belyaeva M.V., Lapina E.O., Etiological factors of hyperlipidemia in dogs, Issues of legal regulation in veterinary medicine, 2014, No. 2, pp. 30-33., Annikov V.V., Belyaeva M.V., Lapina E.O., Etiological factors of hyperlipidemia in dogs, Issues of legal regulation in veterinary medicine, 2014, No. 2, pp. 30-33.

2. World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation, Geneva, 2007, 46 p., World Health Organization. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation, Geneva, 2007, 46 p.

3. Ganshina I.V., Sudyina G.F., Sanina V.Yu., Kozhevnikova T.N., Pronin A.V., Narovlyansky A.N., Sukhanova S.A., Proskurina O.V., Mitrokhin N .M., Sanin A.V., Phosphorylated polyprenols are a new class of compounds with anti-inflammatory and bronchodilator activity, Infection and Immunity, 2011, Vol. 1, No. 4, pp. 355-360., Ganshina I.V., Sudyina G.F., Sanina V.Yu., Kozhevnikova T.N., Pronin A.V., Narovlyansky A.N., Sukhanova S.A., Proskurina O.V., Mitrokhin N .M., Sanin A.V., Phosphorylated polyprenols are a new class of compounds with anti-inflammatory and bronchodilator activity, Infection and Immunity, 2011, Vol. 1, No. 4, pp. 355-360.

4. Elagin R.I., Cost-effectiveness of treating hyperlipidemia in patients with diabetes mellitus, Consilium Medicum, 2001, Vol. 3, No. 2, pp. 102-103 (In russ.)., Elagin R.I., Cost-effectiveness of treating hyperlipidemia in patients with diabetes mellitus, Consilium Medicum, 2001, Vol. 3, No. 2, pp. 102-103 (In russ.).

5. Ignatenko N., Diabetes mellitus in dogs, VetPharma, 2012, No.3, pp. 46-51 (In russ)., Ignatenko N., Diabetes mellitus in dogs, VetPharma, 2012, No.3, pp. 46-51 (In russ).

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New Approaches to the Prevention and Treatment of Viral Diseases;Archivum Immunologiae et Therapiae Experimentalis;2021-04-03